Mitomycin C: Experience in the United States, with emphasis on gastric cancer Philip S. ScheinJohn S. MacdonaldPaul V. Wooley Short Review Pages: 73 - 75
The fluoropyrimidines: Biochemical mechanisms and design of clinical trials Michael A. FriedmanWolfgang Sadée Short Review Pages: 77 - 82
The role of antitumor antibiotics in current oncologic practice Hugh L. Davis Jr.Daniel D. von HoffMarcel Rozencweig Short Review Pages: 83 - 90
New natural products of interest under development at the National Cancer Institute John DourosMatthew Suffness Original Papers Pages: 91 - 100
Initial clinical experience with a simultaneous combination of 2,4-diamino-5(3′,4′-dichlorophenyl)-6-methylpyrimidine (DDMP) with folinic acid Pierre AlbertoRenate PeytremannMario Beretta-Piccoli Original Papers Pages: 101 - 105
Combination chemotherapy for advanced non-Hodgkin's lymphoma of unfavourable histology T. A. ListerM. H. CullenD. Crowther Original Papers Pages: 107 - 112
Prognosis and treatment of acute lymphoblastic leukemia C. JacquillatM. WeilJ. Bernard Original Papers Pages: 113 - 122